Normal levels of cerebrospinal fluid hypocretin-1 and daytime sleepiness during attacks of relapsing-remitting multiple sclerosis and monosymptomatic optic neuritis

Multiple Sclerosis

Volumn 14, Issue 6, 2008, Pages 734-738

  Knudsen, Stine ^a   Jennum, P J ^b   Korsholm, K ^a   Sheikh, S P ^a   Gammeltoft, S ^c   Frederiksen, J L ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Glostrup Research Institute   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

CSF hypocretin 1; Excessive daytime sleepiness; Multiple sclerosis; Narcolepsy; Optic neuritis

Indexed keywords

OREXIN A;

ADULT; ARTICLE; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DISEASE ASSOCIATION; EPWORTH SLEEPINESS SCALE; FEMALE; HUMAN; HYPOTHALAMUS LESION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NARCOLEPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PATHOPHYSIOLOGY; PROTEIN CEREBROSPINAL FLUID LEVEL; RELAPSE; REMISSION;

ADULT; DISORDERS OF EXCESSIVE SOMNOLENCE; FEMALE; HUMANS; HYPOTHALAMUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NEUROPEPTIDES; OPTIC NEURITIS; RECURRENCE; SLEEP STAGES;

EID: 48349099880     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458508088939     Document Type: Article

References (30)

1. Younger, DS, Pedley, TA, Thorpy, MJ. Multiple sclerosis and narcolepsy: possible similar genetic susceptibility. Neurology 1991; 41: 447-448.
2. Duquette, P, Decary, F, Pleines, J, Boivin, D, Lamoureux, G, Cosgrove, JB, et al. Clinical sub-groups of multiple sclerosis in relation to HLA: DR alleles as possible markers of disease progression. Can J Neurol Sci 1985; 12: 106-110.
3. Mignot, E, Lin, X, Arrigoni, J, Macaubas, C, Olive, F, Hallmayer, J, et al. DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black Americans. Sleep 1994; 17: S60-S67.
4. Ekbom, K. Familial Multiple sclerosis associated with narcolepsy. Arch Neurol 1966; 15: 337-344.
5. Malik, S, Boeve, BF, krahn, LE, Silber, MH. Narcolepsy associated with other central nervous system disorders. Neurology 2001; 57: 539-541.
6. Schrader, H, Gotlibsen, OB, Skomedal, GN. Multiple sclerosis and narcolepsy/cataplexy in a monozygotic twin. Neurology 1980; 30: 105-108.
7. Mignot, E. Genetic and familial aspects of narcolepsy. Neurology 1999; 50: S16-S22.
8. Knudsen, S, Jennum, PJ. Narcolepsy - new implications of molecular biology. Ugeskr Laeger 2006; 168: 3699-3704.
9. Peyron, C, Faraco, J, Rogers, W, Ripley, B, Overeem, S, Charnay, Y, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000; 6: 991-997.
10. Nishino, S, Ripley, B, Overeem, S, Lammers, GJ, Mignot, E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000; 355: 39-40.
11. Poirier, G, Montplaisir, J, Dumont, M, Duquette, P, Decary, F, Pleines, J, et al. Clinical and sleep laboratory study of narcoleptic symptoms in multiple sclerosis. Neurology 1987; 37: 693-695.
12. Rumbach, L, Tongio, MM, Warter, JM, Collard, M, Kurtz, D. Multiple sclerosis, sleep latencies and HLA antigens. J Neurol 1989; 236: 309-310.
13. Frauscher, B, Egg, R, Brandauer, E, Ulmer, H, Berger, T, Poewe, W, et al. Daytime sleepiness is not increased in mild to moderate multiple sclerosis: a pupillographic study. Sleep Med 2005; 6: 543-547.
14. Taphoorn, MJ, van Someren, E, Snoek, FJ, Strijers, RL, Swaab, DF, Visscher, F, et al. Fatigue, sleep disturbances and circadjan rhythm in multiple sclerosis. J Neurol 1993; 240: 446-448.
15. Kanbayashi, T, Ishiguro, H, Aizawa, R, Saito, Y, Ogawa, Y, Abe, M, et al. Hypocretin-1 (orexin-A) concentrations in cerebrospinal fluid are low in patients with Guillain-Barré syndrome. Psychiatry Clin Neurosci 2002; 56: 273-274.
16. Nishino, S, Ripley, B, Overeem, S, Nevsimalova, S, Lammers, GJ, Vankova, J, et al. Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy. Ann Neurol 2001; 50: 381-388.
17. Iseki, K, Mezaki, T, Oka, Y, Terada, K, Tomimoto, H, Miki, Y, et al. Hypersomnia in MS. Neurology 2002; 59: 2006-2007.
18. Kato, T, Kanbayashi, T, Yamamoto, K, Nakano, T, Shimizu, T, Hashimoto, T, et al. Hypersomnia and low CSF hypocretin-1 (orexin-A) concentration in a patient with multiple sclerosis showing billateral hypothalamic lesions. Intern Med 2003; 42: 743-745.
19. Johns, MW. A new method, for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14: 540-545.
20. Mignot, E, Lammers, GJ, Ripley, B, Okun, M, Nevsimalova, S, Overeem, S, et al. The role of cerebrospinal fluid hypocretin measurements in the diagnosis of narcolepsy and other hypersomnia. Arch Neurol 2002; 59: 1553-1562.
21. Knudsen, S, Mikkelsen, JD, Jennum, P. Antibodies in nancolepsy-cataplexy patient serum bind to rat hypocretin neurons. Neuroreport 2007; 18: 77-79.
22. Berg, O, Hanley, J. Narcolepsy in two cases of multiple sclerosis. Acta Neurol Scand 1963; 39: 252-256.
23. Ripley, B, Overeem, S, Fujiki, N, Nevsimalova, S, Uchino, M, Yesavage, J, et al. CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology 2001; 57: 2253-2258.
24. Stanton, BR, Barnes, F, Silber, E. Sleep and fatigue in multiple sclerosis. Mult Scler 2006; 12: 481-486.
25. Bo, L, Geurts, JJ, Mork, SJ, Van der Valk, P. Grey matter pathology in multiple sclerosis. Acta Neurol Scand Suppl 2006; 183: 48-50.
26. Huitinga, I, De Groot, CJ, Van der Vaik, P, Kamphorst, W, Tilders, FJ, Swaab, DF. Hypothalamic lesions in multiple sclerosis. J Neuropathol Exp Neurol 2001; 60: 1208-1218.
27. Oka, Y, Kanbayashi, T, Mezaki, T, Iseki, K, Matsubayashi, J, Murakami, G, et al. Low CSF hypocretin-1/orexin-A associated with hypersomnia secondary to hypothalamic lesion.in a case of multiple sclerosis. J Neurol 2004; 251: 885-886.
28. Rao, DG, Singhal, BS. Secondary narcolepsy in a case of multiple sclerosis. J Assoc Physicians India 1997; 45: 321-322.
29. Gerashchenko, D, Murillo-Rodriguez, E, Lin, L, Xu, M, Hallett, L, Nishino, S, et al. Relationship between CSF hypocretin levels and hypocretin neuronal loss. Exp Neurol 2003; 184: 1010-1016.
30. Beck, RW, Trobe, JD, Moke, PS, Gal, RI, Xing, D, Bhatti, MT, et al. High- and low-risk profiles for the development of multiple sclerosis within 40 years after optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol 2003; 121: 944-949.